Search clinical trials for: Modulation of FiO2

Total 10000 results

Hebei Medical University

Recruiting

Clinical Observation of ICI Combined With Recombinant Human Endostatin on Leptomeningeal Metastasis of Lung Cancer

Leptomeningeal Metastasis | Immune Checkpoint Inhibitor | Endostatin

China
Sun Yat-sen University

Recruiting

TACE Combined With Sintilimab Plus Bevacizumab Biosimilar in Hepatocellular Carcinoma (BCLC-C Stage ): a Prospective Single-arm Phase II Clinical Study (T-Double)

Hepatocellular Carcinoma

China
Hospices Civils de Lyon

Completed

Assessment of the Efficacy of Bevacizumab in Combination With Folfiri as Second-line Treatment in Patients Suffering From an Advanced Inoperable Poorly Differentiated Neuroendocrine Carcinoma of an Unknown or Gastroentero-pancreatic Primary Cancer (BEVANEC)

Neuroendocrine Carcinomas

France
National Cancer Institute (NCI)

Completed

Carboplatin and Bevacizumab for Recurrent Ependymoma

Ependymoma | Anaplastic Ependymoma

United States
Benha University

Completed

Brolucizumab Versus Aflibercept on Visual and Anatomical Outcomes in Diabetic Macular Edema (Anti-VEGF)

Anti-VEGF Therapy

Egypt
University Hospital, Caen

Terminated

Intraventricular Fibrinolysis for Aneurysmal Subarachnoid Hemorrhage. (FIVHeMA)

Subarachnoid Hemorrhage

France
St. Joseph's Hospital and Medical Center, Phoenix
The Cleveland Clinic; National Institute on Aging (NIA)

Completed

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients (MCLENA-1)

Cognitive Dysfunction | Neurodegeneration | Cognitive Impairment, Mild | Amyloid Plaque | Inflammation, Brain

United States
Benha University

Completed

Assessing Combined Bevacizumab-Mitomycin C Use During Ahmed Valve Revision in Recurrent Pediatric Glaucoma (MMC glaucoma)

Pediatric Glaucoma

Egypt
Endo Pharmaceuticals

Completed

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks (APHRODITE)

Cellulite | Edematous Fibrosclerotic Panniculopathy

United States
Beijing Suncadia Pharmaceuticals Co., Ltd

Completed

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Prevention of Venous Thromboembolism After Knee Arthroplasty

China
Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Neovascular Age-Related Macular Degeneration

China
Campbell Clinic

Enrolling by invitation

Extended Oral Tranexamic Acid After Total Knee Arthroplasty

Pain, Postoperative | Osteo Arthritis Knee

United States
Sorlandet Hospital HF

Completed

Mechanisms of Retinal Revascularization and Clinical Indicators of Neovascular AMD Relapse

Wet Macular Degeneration

Norway
Lawrence Charles Hookey
Queen's University

Completed

Tranexamic Acid to Prevent Bleeding After Endoscopic Resection of Large Colorectal Polyps: A Pilot Project

Polyp, Colorectal

Canada
Assiut University

Completed

Tranexamic Acid During Telescoping Nail Application In Osteogenesis Imperfecta

Osteogenesis Imperfecta

Egypt
Bayer
Regeneron Pharmaceuticals

Completed

Japanese Treat and Extend Study of Aflibercept in Neovascular Age-related Macular Degeneration (ALTAIR)

Wet Macular Degeneration

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Eylea Post Marketing Surveillance(PMS)

Macular Degeneration

Korea, Republic of
Bayer
Regeneron Pharmaceuticals

Completed

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy (PERSEUS-IT)

Wet Macular Degeneration

Italy
Bayer
Regeneron Pharmaceuticals

Completed

Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMD (RAINBOW)

Wet Macular Degeneration

France
MorphoSys AG

Completed

Open Label Study to Evaluate the Safety and Efficacy of Lenalidomide With MOR00208 in Patients With R-R DLBCL (L-MIND)

Diffuse Large B-cell Lymphoma

Spain, United States, United Kingdom, Italy, Poland, Belgium, Germany, Czechia, France, Hungary
SCRI Development Innovations, LLC
Novartis

Completed

INC280 Combined With Bevacizumab in Patients With Glioblastoma Multiforme

Renal Cell Carcinoma | Colorectal Cancer | Glioblastoma Multiforme | Gliosarcoma

United States
Bayer

Completed

A Study to Learn More About How Drug Aflibercept Works in Canadian Patients With Reduced Vision Caused by New Blood Vessels Growing in the Eye (Myopic Choroidal Neovascularization or mCNV) (REALM)

Myopic Choroidal Neovascularization

Canada
Bayer
Regeneron Pharmaceuticals

Completed

EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan

Macular Degeneration

Japan
Assiut University
Aswan University Hospital

Completed

TPA in Acute Stroke With COVID Verus Non-COVID-19 Patients (rTPA)

Acute Ischemic Stroke

Egypt
Assiut University

Completed

Evaluation of the Efficacy and Safety of Single Dose Tranexamic Acid in Reducing Blood Loss During Colorectal Cancer Surgery

Colorectal Surgery

Egypt
Nanjing University

Active, not recruiting

Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome

Adenomyosis | Assisted Reproductive Technology

China
University Medical Center Groningen
Helmholtz Zentrum München

Unknown

Detection of Early Esophageal Cancer by NIR-FME. (ESCEND)

Barrett Esophagus

Netherlands
Moorfields Eye Hospital NHS Foundation Trust
Novartis

Completed

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation (LUCIDATE)

Diabetic Retinopathy

United Kingdom
Centre Hospitalier de Montauban

Completed

Efficacy of Intra-auricular Tranexamic Acid in Total Knee Arthroplasty

Postoperative Hemorrhage

France
Total Definer Research Group

Completed

Use of Tranexamic Acid in Liposculpture

Blood Loss, Surgical

Colombia, Mexico
The University of Texas Health Science Center at...

Completed

TH-302 in Combination With Bevacizumab for Glioblastoma

Glioblastoma

United States
University Medical Center Groningen
Leiden University Medical Center

Terminated

Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma (PENGUIN)

Pancreatic Cancer | Pancreatic Adenocarcinoma

Netherlands
Bayer
Regeneron Pharmaceuticals

Completed

Evaluate the Effectiveness of Intravitreal (IVT) Aflibercept Injection in Clinical Practice in naïve Patients With Neovascular Age-related Macular Degeneration (nAMD) (REALE)

Macular Degeneration

Spain
The University of Texas Health Science Center,...

Withdrawn

The Effect of Tranexamic Acid on Blood Loss and Transfusion Requirements Following Open Femur Fracture Surgery

Blood Loss Following Open Femur Fracture Surgery
Yeungnam University College of Medicine

Unknown

Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion With Macular Edema

Korea, Republic of
West China Hospital

Unknown

Low Molecular Weight Heparin for the Prevention of Early TIPS Dysfunction

Liver Cirrhosis | Portal Hypertension

China
Bayer

Completed

Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. (AQUA)

Macular Edema

Spain, Canada, Switzerland, Portugal, Austria, Poland, Slovakia, United Kingdom, France, Czechia, Germany, Hungary, Italy, Lithuania
Lymphoma Study Association

Completed

Lenalidomide and R-CHOP in B-cell Lymphoma (R2CHOP-1)

Lymphoma, Large B-Cell, Diffuse | Follicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma

France
Abramson Cancer Center of the University of Pennsylvania

Withdrawn

DCE-MRI PET Bevacizumab Study in Rectal Cancer

Rectal Cancer Patients
Taipei Veterans General Hospital, Taiwan

Completed

Intraarticular Injection of Tranexamic Acid Reduced Postoperative Hemarthrosis in Arthroscopic Anterior Cruciate Ligament Reconstruction

Anterior Cruciate Ligament Reconstruction

Taiwan
Yonsei University

Completed

Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver Mets

Colorectal Cancer | Liver Metastasis

Korea, Republic of
Harbin Medical University
Sun Yat-sen University; Fudan University; Cancer Institute and Hospital, Chinese... and other collaborators

Unknown

XELOX+Bevacizumab and XELIRI + Bevacizumab Alternative Regimen as First-line Treatment for Advanced Colorectal Cancer

Colorectal Neoplasms | Chemotherapy

China
Hoffmann-La Roche

Completed

A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Participants With Recurrent Glioblastoma

Glioblastoma

United States, United Kingdom, France, Italy, Spain, Germany, Canada, Switzerland
Anemia Working Group Romania

Withdrawn

Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic Hemodialysis

Diabetes Mellitus | Hemodialysis

Romania
Genentech, Inc.

Completed

A Study to Evaluate the Safety and Pharmacology of DNIB0600A in Participants With Platinum-Sensitive Ovarian Cancer or Non-Squamous Non-small Cell Lung Cancer

Non-Squamous Non-Small Cell Lung Cancer

United States
Bayer
RTI Health Solutions

Completed

Evaluation of Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept

Macular Degeneration

France, Germany, Spain, Italy, United Kingdom
Leo W. Jenkins Cancer Center
Genentech, Inc.

Withdrawn

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Cervical Cancer

United States
Bayer
Regeneron Pharmaceuticals

Completed

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Wet Macular Degeneration

Japan
University Medical Center Groningen

Unknown

Feasibility Study of Using Molecular Fluorescence Guided Surgery in Endometriosis (Endo-light)

Endometriosis

Netherlands
William Beaumont Hospitals

Completed

Tranexamic Acid in Reverse Total Shoulder Arthroplasty (TXA)

Blood Loss, Surgical | Intraoperative Complications | Complications; Arthroplasty | Shoulder Joint Disease

United States

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations